Seongnam-si, South Korea

Ki-weon Seo

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.7

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ki-weon Seo: Innovator in Respiratory Syncytial Virus Research

Introduction

Ki-weon Seo is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of virology, particularly in the development of vaccines for respiratory syncytial virus (RSV). With a total of 3 patents to his name, Seo's work is paving the way for advancements in vaccine technology.

Latest Patents

Seo's latest patents include innovative approaches to combat respiratory syncytial virus. One of his notable inventions is a respiratory syncytial virus recombinant F protein and vaccine composition containing the same. This invention provides a recombinant fusion protein that is soluble and retains an F protein trimer, which is expected to induce excellent immune responses. Another significant patent is for a recombinant RSV live vaccine strain and its preparation method. This invention offers a recombinant attenuated RSV that maintains infectability while ensuring excellent safety and stability.

Career Highlights

Ki-weon Seo is currently associated with Sk Bioscience Co., Ltd., where he continues to work on groundbreaking research in vaccine development. His expertise in virology and immunology has positioned him as a key figure in the fight against viral infections.

Collaborations

Seo collaborates with talented individuals in his field, including coworkers Eun-som Kim and Teawoo Kwon. Their combined efforts contribute to the advancement of innovative solutions in vaccine research.

Conclusion

Ki-weon Seo's contributions to respiratory syncytial virus research highlight his role as an influential inventor in the field of virology. His patents reflect a commitment to developing effective vaccines that can significantly impact public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…